Recordati Industria Chimica e Farmaceutica SpA Eulerpool naujienos

Recordati Industria Chimica e Farmaceutica SpA akcijų naujienos

Recordati Industria Chimica e Farmaceutica SpA stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Recordati Industria Chimica e Farmaceutica SpA naujienas mes pateikiame čia.

• lapkričio 11 d. ·

  Yahoo
  Recordati SpA (RICFY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
• lapkričio 8 d. ·

  SeekingAlpha
  Recordati Industria Chimica e Farmaceutica S.p.A. 2024 Q3 - Results - Earnings Call Presentation
• lapkričio 8 d. ·

  SeekingAlpha
  Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q3 2024 Earnings Call Transcript
• lapkričio 8 d. ·

  Yahoo
  RECORDATI: CONTINUED DOUBLE-DIGIT GROWTH IN THE FIRST NINE MONTHS OF 2024 - REVENUE +12.0%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +9.5%
• spalio 22 d. ·

  TipRanks
  Recordati price target raised to EUR 48 from EUR 45 at Barclays
• spalio 22 d. ·

  Thefly.com
  Recordati price target raised by EUR 3 at Barclays
• spalio 9 d. ·

  Yahoo
  Recordati SpA (RICFY) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
• spalio 5 d. ·

  TipRanks
  Kepler Capital Reaffirms Their Hold Rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
• spalio 4 d. ·

  Yahoo
  Sanofi Sells Global Rights To Rare Autoimmune Drug Enjaymo For $825M Upfront To Italian Firm Recordati
• spalio 4 d. ·

  Yahoo
  Recordati to acquire worldwide rights to Sanofi’s antibody Enjaymo